USFDA had conducted an un-announced audit of Jeevan Scientific Technology Ltd's (JSTL) clinical pharmacology centre facility. The purpose of this audit was to review the BA/BE studies. The auditors started the review on January 9, 2018 and completed on January 12, 2018.
The auditors completed the audit with one study specific observation (One 483). JSTL team is working on addressing this observation within the stipulated timelines.
Shares of Jeevan Scientific Technology Ltd was last trading in BSE at Rs.56 as compared to the previous close of Rs. 57.5. The total number of shares traded during the day was 6530 in over 36 trades.
The stock hit an intraday high of Rs. 57.9 and intraday low of 54.65. The net turnover during the day was Rs. 358634.